Literature DB >> 27899423

MYC Mediates mRNA Cap Methylation of Canonical Wnt/β-Catenin Signaling Transcripts By Recruiting CDK7 and RNA Methyltransferase.

Valeriya Posternak1, Matthew H Ung1, Chao Cheng1, Michael D Cole2.   

Abstract

MYC is a pleiotropic transcription factor that activates and represses a wide range of target genes and is frequently deregulated in human tumors. While much is known about the role of MYC in transcriptional activation and repression, MYC can also regulate mRNA cap methylation through a mechanism that has remained poorly understood. Here, it is reported that MYC enhances mRNA cap methylation of transcripts globally, specifically increasing mRNA cap methylation of genes involved in Wnt/β-catenin signaling. Elevated mRNA cap methylation of Wnt signaling transcripts in response to MYC leads to augmented translational capacity, elevated protein levels, and enhanced Wnt signaling activity. Mechanistic evidence indicates that MYC promotes recruitment of RNA methyltransferase (RNMT) to Wnt signaling gene promoters by enhancing phosphorylation of serine 5 on the RNA polymerase II carboxy-terminal domain, mediated in part through an interaction between the TIP60 acetyltransferase complex and TFIIH. IMPLICATIONS: MYC enhances mRNA cap methylation above and beyond transcriptional induction. Mol Cancer Res; 15(2); 213-24. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27899423      PMCID: PMC5290160          DOI: 10.1158/1541-7786.MCR-16-0247

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  48 in total

1.  Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line.

Authors:  James DiRenzo; Sabina Signoretti; Noriaki Nakamura; Ramon Rivera-Gonzalez; William Sellers; Massimo Loda; Myles Brown
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

2.  Transcriptional amplification in tumor cells with elevated c-Myc.

Authors:  Charles Y Lin; Jakob Lovén; Peter B Rahl; Ronald M Paranal; Christopher B Burge; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

3.  c-Myc regulates mammalian body size by controlling cell number but not cell size.

Authors:  A Trumpp; Y Refaeli; T Oskarsson; S Gasser; M Murphy; G R Martin; J M Bishop
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

4.  The transcriptional program of a human B cell line in response to Myc.

Authors:  M Schuhmacher; F Kohlhuber; M Hölzel; C Kaiser; H Burtscher; M Jarsch; G W Bornkamm; G Laux; A Polack; U H Weidle; D Eick
Journal:  Nucleic Acids Res       Date:  2001-01-15       Impact factor: 16.971

5.  Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.

Authors:  V Korinek; N Barker; P J Morin; D van Wichen; R de Weger; K W Kinzler; B Vogelstein; H Clevers
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

6.  CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer.

Authors:  Edmond Chipumuro; Eugenio Marco; Camilla L Christensen; Nicholas Kwiatkowski; Tinghu Zhang; Clark M Hatheway; Brian J Abraham; Bandana Sharma; Caleb Yeung; Abigail Altabef; Antonio Perez-Atayde; Kwok-Kin Wong; Guo-Cheng Yuan; Nathanael S Gray; Richard A Young; Rani E George
Journal:  Cell       Date:  2014-11-06       Impact factor: 41.582

7.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

8.  CDK7-dependent transcriptional addiction in triple-negative breast cancer.

Authors:  Yubao Wang; Tinghu Zhang; Nicholas Kwiatkowski; Brian J Abraham; Tong Ihn Lee; Shaozhen Xie; Haluk Yuzugullu; Thanh Von; Heyuan Li; Ziao Lin; Daniel G Stover; Elgene Lim; Zhigang C Wang; J Dirk Iglehart; Richard A Young; Nathanael S Gray; Jean J Zhao
Journal:  Cell       Date:  2015-09-24       Impact factor: 41.582

9.  The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding.

Authors:  Victoria H Cowling; Michael D Cole
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

Review 10.  The mRNA cap-binding protein eIF4E in post-transcriptional gene expression.

Authors:  Tobias von der Haar; John D Gross; Gerhard Wagner; John E G McCarthy
Journal:  Nat Struct Mol Biol       Date:  2004-06       Impact factor: 15.369

View more
  16 in total

Review 1.  Role of RNA modifications in cancer.

Authors:  Isaia Barbieri; Tony Kouzarides
Journal:  Nat Rev Cancer       Date:  2020-04-16       Impact factor: 60.716

2.  Oncogenic PIK3CA mutations increase dependency on the mRNA cap methyltransferase, RNMT, in breast cancer cells.

Authors:  Sianadh Dunn; Olivia Lombardi; Radoslaw Lukoszek; Victoria H Cowling
Journal:  Open Biol       Date:  2019-04-26       Impact factor: 6.411

3.  MYC Hyperactivates Wnt Signaling in APC/CTNNB1-Mutated Colorectal Cancer Cells through miR-92a-Dependent Repression of DKK3.

Authors:  Priyanka Sehgal; Claudia Lanauze; Xin Wang; Katharina E Hayer; Manuel Torres-Diz; N Adrian Leu; Yogev Sela; Ben Z Stanger; Christopher J Lengner; Andrei Thomas-Tikhonenko
Journal:  Mol Cancer Res       Date:  2021-09-30       Impact factor: 6.333

4.  Targeting CDK7 increases the stability of Snail to promote the dissemination of colorectal cancer.

Authors:  Yan Zhou; Linlin Lu; Guanmin Jiang; Zhuojia Chen; Jiexin Li; Panpan An; Likun Chen; Jun Du; Hongsheng Wang
Journal:  Cell Death Differ       Date:  2018-11-19       Impact factor: 15.828

Review 5.  MYC protein interactors in gene transcription and cancer.

Authors:  Diana Resetca; Cornelia Redel; Corey Lourenco; Peter Lin; Alannah S MacDonald; Roberto Ciaccio; Tristan M G Kenney; Yong Wei; David W Andrews; Maria Sunnerhagen; Cheryl H Arrowsmith; Brian Raught; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2021-06-29       Impact factor: 60.716

6.  WNT signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-mediated gene gating.

Authors:  Barbara A Scholz; Noriyuki Sumida; Anita Göndör; Rolf Ohlsson; Carolina Diettrich Mallet de Lima; Ilyas Chachoua; Mirco Martino; Ilias Tzelepis; Andrej Nikoshkov; Honglei Zhao; Rashid Mehmood; Emmanouil G Sifakis; Deeksha Bhartiya
Journal:  Nat Genet       Date:  2019-11-29       Impact factor: 38.330

7.  Integrated requirement of non-specific and sequence-specific DNA binding in Myc-driven transcription.

Authors:  Paola Pellanda; Mattia Dalsass; Marco Filipuzzi; Alessia Loffreda; Alessandro Verrecchia; Virginia Castillo Cano; Hugo Thabussot; Mirko Doni; Marco J Morelli; Laura Soucek; Theresia Kress; Davide Mazza; Marina Mapelli; Marie-Eve Beaulieu; Bruno Amati; Arianna Sabò
Journal:  EMBO J       Date:  2021-04-01       Impact factor: 11.598

8.  MYC promotes cancer progression by modulating m6 A modifications to suppress target gene translation.

Authors:  Gongwei Wu; Caixia Suo; Ying Yang; Shengqi Shen; Linchong Sun; Shi-Ting Li; Yingli Zhou; Dongdong Yang; Yan Wang; Yongping Cai; Nana Wang; Huafeng Zhang; Yun-Gui Yang; Jie Cao; Ping Gao
Journal:  EMBO Rep       Date:  2021-01-11       Impact factor: 8.807

Review 9.  Controlling the Master: Chromatin Dynamics at the MYC Promoter Integrate Developmental Signaling.

Authors:  Olga Zaytseva; Leonie M Quinn
Journal:  Genes (Basel)       Date:  2017-04-11       Impact factor: 4.096

Review 10.  To cap it all off, again: dynamic capping and recapping of coding and non-coding RNAs to control transcript fate and biological activity.

Authors:  Klb Borden; B Culjkovic-Kraljacic; V H Cowling
Journal:  Cell Cycle       Date:  2021-07-09       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.